Literature DB >> 30803898

Spectral CT Imaging in the Differential Diagnosis of Small Bowel Adenocarcinoma From Primary Small Intestinal Lymphoma.

Chuang-Bo Yang1, Nan Yu2, Yong-Jun Jian3, Yong Yu3, Hai-Feng Duan3, Xi-Rong Zhang3, Guang-Ming Ma3, Youmin Guo3, Xiaoyi Duan3.   

Abstract

PURPOSE: To investigate the value of dual-energy spectral computed tomography (CT) imaging in the differential diagnosis of small bowel adenocarcinoma (SBA) from primary small intestinal lymphoma (PSIL).
MATERIALS AND METHODS: We retrospectively analyzed the images of 27 SBA cases and 15 PSIL cases. These patients underwent spectral CT imaging in the arterial phase (AP) and venous phase (VP). CT attenuation values of tumors at different energy levels were measured to generate spectral attenuation curve and to calculate curve slope (λHU). Iodine concentration (IC) in tumors at AP and VP were measured and normalized to that of aorta as normalized iodine concentration (NIC). Independent samples t test was used to analyze the spectral CT parameters; Receiver operating characteristic curves were generated to evaluate the diagnostic efficacy of each parameter.
RESULTS: There were significant differences between SBA and PSIL in IC (2.09 ± 0.71 vs 1.33 ± 0.15 mg/ml), NIC (0.20 ± 0.06 vs 0.13 ± 0.02) and slope (λHU) (2.78 ± 1.06 vs 1.86 ± 0.30) in AP and (1.86 ± 0.68 vs 1.37 ± 0.18 mg/ml for IC; 0.47 ± 0.13 vs 0.33 ± 0.02 for NIC and 2.00 ± 0.56 vs 1.50 ± 0.26 for λHU) in VP (all p < 0.05). For the CT value measurement, there were significant differences between SBA and PSIL in the 40-60keV energy range (p < 0.05), but not in the 70-140keV range (p > 0.05). Using 1.38 mg/ml as a threshold value for iodine concentration at AP, one could obtain the area-under-curve of 0.93 for receiver operating characteristic study and sensitivity of 94% and specificity of 85% for differentiating SBA from PSIL. The sensitivity and specificity values were significantly higher than the respective values of 62% and 60% with the conventional CT numbers at 70keV.
CONCLUSION: Quantitative parameters obtained in spectral CT, especially iodine concentration in AP, provide high accuracy for differentiating SBA from PSIL.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  CT imaging spectroscopy; Differential diagnosis; Lymphoma; Small intestine

Year:  2019        PMID: 30803898     DOI: 10.1016/j.acra.2018.08.020

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

Review 1.  Epidemiology, Risk Factors and Diagnosis of Small Bowel Adenocarcinoma.

Authors:  Thomas Aparicio; Atanas Pachev; Pierre Laurent-Puig; Magali Svrcek
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

2.  CT Texture Analysis for Preoperative Identification of Lymphoma from Other Types of Primary Small Bowel Malignancies.

Authors:  Shunli Liu; Chuanyu Zhang; Ruiqing Liu; Shaoke Li; Fenglei Xu; Xuejun Liu; Zhiming Li; Yabin Hu; Yaqiong Ge; Jiao Chen; Zaixian Zhang
Journal:  Biomed Res Int       Date:  2021-04-02       Impact factor: 3.411

3.  The role of multidetector computed tomography enterography in the evaluation of localized malignant small intestinal lesions: retrospective radiological and pathological experience.

Authors:  Dalia Bayoumi; Doaa Khedr; Ahmed Abdallah; Afaf Taha Ibrahiem; Sherine Refat
Journal:  Pol J Radiol       Date:  2021-11-30

4.  Small bowel obstruction caused by secondary jejunal tumor from renal cell carcinoma: A case report.

Authors:  Gao-Chen Bai; Yue Mi; Yi Song; Jin-Rui Hao; Zhi-Song He; Jie Jin
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

5.  Primary Gastro-Intestinal Lymphoma and Gastro-Intestinal Adenocarcinoma: An Initial Study of CT Texture Analysis as Quantitative Biomarkers for Differentiation.

Authors:  Lin Ding; Sisi Wu; Yaqi Shen; Xuemei Hu; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Life (Basel)       Date:  2021-03-23

6.  Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma.

Authors:  Bei Zhang; Qiong Wu; Xiang Qiu; Xiaobo Ding; Jin Wang; Jing Li; Pengfei Sun; Xiaohan Hu
Journal:  BMC Cancer       Date:  2021-07-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.